Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Expensive Performer

Download real time

1024.50 2.20 (0.22%)

42.34% Gain from 52W Low

4,138 NSE+BSE Volume

NSE 18 Mar, 2025 9:24 AM (IST)

12,553.9

Market Cap

High in industry

0.4

Beta 1Year

Very Low volatility

Alivus Life Sciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alivus Life Sciences Ltd. from all sources in a single place.

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

120 Votes:

Buy 75.0%

Sell 13.33%

Hold 11.67%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >